NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / NTAGI to devise roadmap to introduce ZyCoV-D into inoculation drive
    India

    NTAGI to devise roadmap to introduce ZyCoV-D into inoculation drive

    NTAGI to devise roadmap to introduce ZyCoV-D into inoculation drive
    Written by Varnika Sharma
    (PTI desk)
    Aug 25, 2021, 05:06 pm 2 min read
    NTAGI to devise roadmap to introduce ZyCoV-D into inoculation drive
    COVID-19 vaccine ZyCoV-D received Emergency Use Authorization from the drug regulator on August 20

    The National Technical Advisory Group on Immunization (NTAGI) will soon hold a meeting to devise a roadmap for introducing Zydus Cadila's COVID-19 vaccine in the inoculation drive and prioritizing beneficiaries focusing on those aged 12-18 years with comorbidities. The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received Emergency Use Authorization from the drug regulator on August 20.

    First vaccine to be administered in 12-18 years age group

    The authorization of the vaccine made it the first vaccine to be administered in the age group of 12-18 years in the country. NTAGI Chairman Dr. NK Arora said it is estimated that there are around 12 crore adolescents in the age group of 12-18 years in India and less than one percent of them may have comorbidities.

    Meeting will also focus on prioritization of beneficiaries: NTAGI Chairman

    "The NTAGI's meeting will be held soon to chalk out a roadmap for introducing the three-dose ZyCoV-D vaccine in the ongoing COVID-19 vaccination drive. The meeting will also focus on prioritization of beneficiaries as this vaccine is approved for both adolescents and adults," he said.

    Covishield, COVAXIN being given to only those above 18 years

    "The aim is to develop a priority list with the focus being on adolescents aged 12-18 years with comorbidities," Dr. Arora said. The NTAGI will provide the protocol for the introduction of this vaccine in the immunization drive. Covishield, COVAXIN, and Sputnik V are being given to only those above 18 years and unlike ZyCoV-D, which is three-dose, these are administered in two doses.

    Phase-III clinical trials of ZyCoV-D showed primary efficacy of 66.6%

    The Department of Biotechnology has said that ZyCoV-D is the world's first DNA-based vaccine and when injected produces the spike protein of the SARS-CoV-2 virus and elicits an immune response, which plays a vital role in protection from the disease as well as viral clearance. It said that interim results from Phase-III clinical trials showed primary efficacy of 66.6% for symptomatic RT-PCR positive cases.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Zydus Cadila
    Coronavirus
    COVID-19
    COVID-19 Vaccination

    Latest

    Airtel 5G launched in more cities across Gujarat, Odisha Bharti Airtel
    'Farzi' to 'Thunivu': Exciting OTT weekend watchlist is here OTT releases
    Here's how to come out of a toxic relationship  Relationships
    Lifeguards in Goa get AI assistance for rescue operations Goa

    Zydus Cadila

    Are Indian vaccines effective against Omicron? Here's what manufacturers say Coronavirus
    ZyCoV-D expected to be rolled out in two weeks: Report Coronavirus
    Here are some key drugs being tested for COVID-19 treatment Pfizer
    COVID-19 vaccine trials for ages 3-12 soon: Zydus Cadila MD COVID-19

    Coronavirus

    COVID-19 outbreak has infected 80% of Chinese population China
    COVID-19: WHO urges travelers to mask up amid XBB.1.5 spread World Health Organization
    China: Hospitals cancel New Year holidays to meet patients' requirements China
    #NewsBytesExplainer: What's XBB.1.5, COVID-19 sub-variant triggering cases spike in US  COVID-19

    COVID-19

    Zoom fires 1,300 employees due to "uncertainty of global economy" Zoom
    US reduces visa backlog; appointments for Indians at overseas embassies H-1B Visa
    Kerala: Man gets 3 life-terms for raping, impregnating minor daughter Kerala
    Amid global slowdown predictions, IMF calls India 'bright spot' International Monetary Fund

    COVID-19 Vaccination

    Centre refutes reports on side-effects of COVID-19 vaccines Union Health Ministry
    Chinese residents hesitant of COVID-19 vaccine as cases rise: Reports China
    China may witness over 1 million COVID-19 deaths in 2023 China
    China administers over 1 million COVID-19 vaccine doses a day China

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023